Sandhu Roopinder K, Sheldon Robert S, Savu Anamaria, Kaul Padma
Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada.
Division of Cardiology, University of Calgary, Calgary, Alberta, Canada.
Can J Cardiol. 2017 Apr;33(4):456-462. doi: 10.1016/j.cjca.2016.11.005. Epub 2016 Nov 11.
We examined the prevalence, comorbidity burden, and outcomes of patients who presented to acute care hospitals with a primary diagnosis of syncope over a 10-year period in Canada.
The Canadian Institute for Health Information Discharge Abstract Database (which contains detailed health information from all Canadian provinces and territories except Quebec) was used to identify hospitalizations of patients with a primary diagnosis of syncope (International Classification of Diseases-10th Revision code R55) 20 years of age or older in Canada from 2004 to 2014. Annual age- and sex-standardized hospital discharge rates were calculated. Logistic regression was used to examine patient factors associated with in-hospital mortality, 30-day readmission for any cause, and syncope.
During the 10-year study period, 98,730 hospitalizations occurred for syncope. The age- and sex-standardized hospitalization rate was 0.54 per 1000 population and decreased over time (P < 0.0001). Most patients (63%) were low-risk (Charlson comorbidity index = 0), although the proportion of patients with a Charlson comorbidity index ≥ 3 increased over time. Less than 1% of patients died in-hospital; however, among patients discharged alive, 30-day readmission rates for syncope and any cause were 1.1% and 9.0%, respectively. In-hospital mortality increased with each decade in age (odd ratio, 1.63; 95% confidence interval, 1.48-1.79), was higher in men (odds ratio, 1.37; 95% confidence interval, 1.16-1.63), and in patients with greater comorbidity (P < .0001).
The hospitalization rate for syncope is decreasing over time in Canada. Although the comorbidity burden of hospitalized patients is increasing, most syncope patients are low-risk. Future studies are needed to help understand how standardized diagnostic testing pathways and discharge planning might lead to more efficient and cost-effective syncope management.
我们调查了在加拿大10年期间因晕厥为主诊断入住急诊医院的患者的患病率、合并症负担及预后情况。
利用加拿大卫生信息研究所出院摘要数据库(该数据库包含除魁北克省外所有加拿大省份和地区的详细健康信息)来确定2004年至2014年期间加拿大20岁及以上以晕厥为主诊断(国际疾病分类第10版编码R55)的患者的住院情况。计算年度年龄和性别标准化的医院出院率。采用逻辑回归分析来研究与住院死亡率、任何原因导致的30天再入院率以及晕厥相关的患者因素。
在10年研究期间,因晕厥发生了98730次住院。年龄和性别标准化住院率为每1000人口0.54例,且随时间下降(P < 0.0001)。大多数患者(63%)为低风险(查尔森合并症指数 = 0),尽管查尔森合并症指数≥3的患者比例随时间增加。住院期间死亡的患者不到1%;然而,在存活出院的患者中,晕厥和任何原因导致的30天再入院率分别为1.1%和9.0%。住院死亡率随年龄每增加十岁而升高(比值比,1.63;95%置信区间,1.48 - 1.79),男性更高(比值比,1.37;95%置信区间,1.16 - 1.63),合并症更严重的患者也是如此(P < 0.0001)。
在加拿大,晕厥的住院率随时间下降。尽管住院患者的合并症负担在增加,但大多数晕厥患者为低风险。未来需要开展研究,以帮助了解标准化诊断检测途径和出院计划如何能带来更高效且具成本效益的晕厥管理。